Entries |
Document | Title | Date |
20080226669 | MULTIVALENT PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS - An improved method for recovering the protein expressed by open reading frame 2 from porcine circovirus type 2 is provided. Also provided is recombinant PCV2 ORF2 protein, and immunogenic compositions comprising PCV2 ORF2 protein. Moreover, multivalent combination vaccines are provided which include an immunological agent effective for reducing the incidence of or lessening the severity of PCV2 infection, preferably PCV2 ORF2 protein, or an immunogenic composition comprising PCV2 ORF2 protein, and at least one immunogenic active component of another disease-causing organism in swine, | 09-18-2008 |
20080226670 | CANINE COMBINATION VACCINES - This invention relates to vaccines and methods for protecting dogs against disease caused by | 09-18-2008 |
20080226671 | Vaccines for Mycoplasma bovis and methods of use - The invention of novel, effective vaccines against | 09-18-2008 |
20080254063 | Vaccines and Methods to Treat Canine influenza - The present invention relates to providing new vaccines and treatments for the diseases related to canine influenza virus. It discloses influenza viral antigens, and methods of presenting these antigens to canines, especially dogs. It relates to attenuated and killed vaccines. The present invention relates to experimentally generated canine and equine influenza viruses. invention also includes influenza A, including H3, N8, H3N8, H7N7 and viruses which contain at least one genome segment from an canine or equine influenza virus. The present invention also relates to the use of these viruses in therapeutic compositions to protect canines, dogs in particular, from diseases caused by influenza viruses. | 10-16-2008 |
20080260777 | COMPOSITION AND METHOD FOR CONTROLLING INTESTINAL PATHOGENIC ORGANISMS - An antigen composition for stimulating an immune response in an inoculated avian species to at least one intestinal pathogenic organism includes seven field strains of | 10-23-2008 |
20080311151 | Vaccine For Periodontal Disease - The present invention relates to novel bacterial isolates identified by their 16S rRNA DNA, that cause periodontal disease in companion animals, polynucleotide sequences contained therein, polypeptides encoded by such polynucleotide sequences and vaccines comprising such bacteria, polynucleotides, or polypeptides. Also provided are methods for treating and preventing periodontal disease and kits for detecting and treating periodontal disease kits for detecting and preventing periodontal disease. In addition, methods for assessing the efficacy of a vaccine against periodontal diseases in an animal are provided. | 12-18-2008 |
20090053262 | Combination vaccine for poultry - The present invention relates to a combination vaccine for the protection of poultry against | 02-26-2009 |
20090068223 | COMBINATION VACCINE COMPRISING AN ATTENUATED BOVINE VIRAL DIARRHEA VIRUS - The present invention relates to combination vaccines for the prophylaxis and treatment of microbiological infections in cattle which comprise an attenuated bovine viral diarrhea virus (BVDV) for the prophylaxis and treatment of BVDV caused infections, and a further immunological active component for the prophylaxis and treatment of microbiological infections other than BVDV. | 03-12-2009 |
20090087451 | Methods and Compositions for Vaccination - The invention provides kits, methods and compositions of matter which improve the safety of vaccination. By combining the administration of antiviral drugs, particularly ester derivatives of cidofovir, with the administration of viral vaccines, particularly the variola vaccine DryVax, side effects of the vaccine are diminished without significantly affecting the effectiveness of the vaccine. | 04-02-2009 |
20090092636 | MULTIVALENT PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS - An improved method for recovering the protein expressed by open reading frame 2 from porcine circovirus type 2 is provided. Also provided is recombinant PCV2 ORF2 protein, and immunogenic compositions comprising PCV2 ORF2 protein. Moreover, multivalent combination vaccines are provided which include an immunological agent effective for reducing the incidence of or lessening the severity of PCV2 infection, preferably PCV2 ORF2 protein, or an immunogenic composition comprising PCV2 ORF2 protein, and at least one immunogenic active component of another disease-causing organism in swine, | 04-09-2009 |
20090098157 | Helicobacter Pylori Vaccination - A sterile immunogenic preparation of three purified | 04-16-2009 |
20090104226 | Alphavirus Vectors for Respiratory Pathogen Vaccines - Described herein are compositions and methods for stimulating an immune response to one or more proteins derived from one or more respiratory pathogens. In particular, the invention relates to alphavirus replicons, alphavirus vector constructs, alphavirus replicon particles expressing one or more antigens derived from one or more respiratory pathogens as well as to method of making and using these immunogenic compositions. | 04-23-2009 |
20090110697 | INACTIVATED BOVINE HERPES VIRUS-1 AND METHODS - This invention related to a method of immunizing cattle to reduce the effects of infection by bovine herpes virus 1, including abortion and stillbirth, by administering inactivated bovine herpes virus 1 prior to breeding. | 04-30-2009 |
20090117152 | Mycoplasma Hyopneumoniae Avirulent Adjuvanted Live Vaccine - Provided are immunogenic and vaccine compositions and methods for their preparation and use, which compositions are effective in protecting against, minimizing the severity of, preventing, and/or ameliorating | 05-07-2009 |
20090130141 | Compositions and methods for stimulating an immune response against infectious agents - The invention provides for oral compositions for safely stimulating an immune response to mucoadhesive antigens for protection against infectious agents, particularly influenza viruses using heat-labile, mutant | 05-21-2009 |
20090130142 | Streptococcus Phocae Vaccine - The present invention relates to the use of bacteria of the species | 05-21-2009 |
20090155305 | Manufacture of Vaccines That Contain Both Hepatitis B Virus Surface Antigen and Surfactant - When preparing HBsAg for use in a combination vaccine, it is known to add a non-ionic detergent after the HBsAg has been purified. Adding detergents after purification of HBsAg is not optimal, however, as it requires a separate processing step during manufacture. Thus the invention uses them during HBsAg purification. | 06-18-2009 |
20090162397 | HEAT TREATED BACTERINS, AND EMULSION VACCINES PREPARED FROM SUCH HEAT TREATED BACTERINS - Heat treated bacterins, a method of producing heat treated bacterins, and porcine emulsion vaccines prepared from such heat treated bacterins are disclosed. | 06-25-2009 |
20090175902 | Immunogenic Substances Comprising A Polyinosinic Acid-Polycytidilic Acid Based Adjuvant - The present invention provides a polynucleotide adjuvant (PICKCa) composition and methods of use in eliciting an immune response, in particular a mucosal immune response. The polynucleotide adjuvant comprises of a polyriboinosinic-polyribocytidylic acid (PIC), at least one antibiotic and at least one positive ion. The present invention also provides an immunogenic composition comprising the polynucleotide adjuvant composition together with other immunogenic compositions such as an antigen (e.g., as in a vaccine) selected from viral, bacterial, fungal, parasitic and/or cancer antigens. The present invention further contemplates methods of use of such adjuvant compositions, particularly in eliciting an immune response, in particular a mucosal immune response to an antigenic compound. | 07-09-2009 |
20090175903 | MEASLES SUBUNIT VACCINE - Compositions and methods for making and using therapeutic formulations of measles virus antigens with a Proteosome-based adjuvant are provided. The measles virus antigens may be derived from a variety of sources, such as from recombinant production or from a split antigen preparation. The measles vaccine formulations may be used, for example, in methods for treating or preventing a measles virus infection and eliciting a protective immune response. | 07-09-2009 |
20090202588 | Nucleic acids encoding TGEV and PRRSV sequences for improved expression of PRRSV sequences - The present invention relates to nucleic acids comprising:
| 08-13-2009 |
20090304737 | Vaccine Against Mycoplasma PRRSV - The present invention relates to the use of an immunogenic dose of immunogenic material of | 12-10-2009 |
20090317423 | PCV2 MYCOPLASMA HYOPNEUMONIAE IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS - Multivalent combination vaccines are provided which include an immunological agent effective for reducing the incidence of or lessening the severity of M. hyo infection, preferably M. hyo bacterin, or an immunogenic composition comprising M. hyo bacterin, and at least one immunogenic active component of another disease-causing organism in swine, preferably PCV2 wherein the preferred PCV2 antigen for such a multivalent vaccine is PCV2 ORF 2 protein. | 12-24-2009 |
20100021497 | IPV-DPT VACCINE - The invention provides a process for producing a combined vaccine containing an inactivated Sabin strain of poliovirus, a | 01-28-2010 |
20100028379 | METHODS OF VACCINE ADMINISTRATION - This invention relates to a method of treating a dog for canine diseases comprising administering to the dog therapeutically effective amounts of a vaccine, wherein the vaccine comprises viral antigens, a bacterin, or both, and wherein the vaccine is administered subcutaneously or orally according to the schedules provided herein. | 02-04-2010 |
20100047272 | Therapeutic vaccine comprising mycobacterial heat shock protein 70 - The present invention relates to the use of a mycobacterial heat-shock protein for the manufacture of a vaccine for therapeutic application. | 02-25-2010 |
20100062017 | Pasteurella multocida vaccine - The present invention relates to live attenuated bacteria of the species | 03-11-2010 |
20100080823 | Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants - Compositions are provided which include hyaluronic acid derivatives in combination with vaccine antigens, and optionally adjuvants, for mucosal delivery. Also provided are methods of making the compositions, as well as methods of immunization using the same. | 04-01-2010 |
20100104594 | PATHOGEN FOR BACTERIAL POULTRY DISEASE - The invention belongs to the field of animal health and in particular the causative agent of a new bacterial poultry disease, | 04-29-2010 |
20100136049 | METHODS AND COMPOSITIONS FOR VACCINATION OF POULTRY - The present invention provides methods of inducing an immune response against | 06-03-2010 |
20100143403 | METHODS AND COMPOSITIONS FOR VACCINATION OF POULTRY - The present invention provides methods of inducing an immune response against | 06-10-2010 |
20100150958 | Methods and Compositions for Use of a Coccidiosis Vaccine - The invention relates to new vaccine compositions for vaccinating birds. | 06-17-2010 |
20100158940 | MANUFACTURE OF BOOSTER VACCINES HAVING REDUCED ANTIGEN DOSES - A process for manufacturing a vaccine, wherein the vaccine comprises diphtheria toxoid and tetanus toxoid and, and wherein the process comprises steps of combining (i) a first bulk comprising diphtheria toxoid and tetanus toxoid with (ii) a second bulk comprising tetanus toxoid but no diphtheria toxoid. This arrangement facilitates convenient manufacture of both pediatric and adolescent vaccines from the same bulks: the first bulk can have a diphtheriartetanus ratio that is suitable for pediatric vaccines, and the second bulk can be used to reduce the relative amount of diphtheria toxoid, as found in the adolescent vaccines. | 06-24-2010 |
20100178301 | METHOD OF TREATING PREGNANT COWS AND/OR HEIFERS - The present invention relates to combination vaccines for the prophylaxis and treatment of microbiological infections in cattle which comprise an attenuated bovine viral diarrhea virus (BVDV) for the the prophylaxis and treatment of BVDV caused infections. The invention also relates to a method of vaccinating a pregnant cow. | 07-15-2010 |
20100226937 | COMBINATION VACCINES WITH 1-HYDROXY-2-PHENOXYETHANE PRESERVATIVE - Processes for preparing combination vaccines that include diphtheria and tetanus toxoids, where these two toxoids are used in the processes as a single component containing both toxoids, and also containing 1-hydroxy-2-phenoxyethane. | 09-09-2010 |
20100233204 | Immunogenic Compositions and Methods for Treating and Preventing Animal Infections - The present disclosure relates to multivalent immunogen compositions for treating or preventing diseases or disorders in canines caused by or associated with one or more of canine distemper virus, canine adenovirus (type 1 or type 2), canine parainfluenza virus, canine parvovirus, | 09-16-2010 |
20100233205 | ADJUVANTED ANTIGENIC MENINGOCOCCAL COMPOSITIONS - Compositions comprising a Neisserial antigen and a detoxified ADP-ribosylating toxin are provided. These compositions have been found useful for mucosal immunization, particularly for nasal immunization against | 09-16-2010 |
20100260795 | Carrier Particle for a Microorganism or Subunit Thereof, Pharmaceutical Composition Comprising such Particles, Method for Preparation of this Composition and Its Use in the Treatment of Animals - The invention pertains to a carrier particle comprising a hydrophilic phase containing a micro-organism and/or subunit thereof, the hydrophilic phase being dispersed in a hydrophobic continuous phase being solid at room temperature, wherein the hydrophobic phase is constituted to undergo a solid-to-liquid conversion at a temperature above room temperature, the conversion comprising a first order transition. The invention also pertains to a pharmaceutical composition comprising said particles, a method for preparation the pharmaceutical composition and the use of this composition in the treatment of an animal. | 10-14-2010 |
20100266628 | MACROCYCLIC LACTONE COMBINATION COMPOSITIONS, VACCINES AND METHODS FOR PRODUCING SAME - An injectable composition, capable of preventing or controlling parasitic, viral, or bacterial infections or diseases, for example scours, in pregnant cows and viral infections or diseases in neonatal calves by parenterally administering to each cow in a herd of pregnant cows, a dose of a combination composition comprising: (a) at least one inactivated viral component derived from rotavirus and/or coronavirus; (b) a macrocyclic lactone active compound; and (c) a pharmaceutically acceptable parenteral carrier and preservative. The injectable compositions which include eprinomectin result in extremely low milk residues. | 10-21-2010 |
20100266629 | Cattle Reproductive Disease Vaccines - The present invention relates to combination vaccines and methods for treating or preventing diseases or disorders in an animal caused by infection by Bovine Viral Diarrhea Virus (BVDV) Types 1 and 2, Bovine Herpes Virus Type-1 (BHV-1), Bovine Respiratory Syncytial Virus (BRSV), Parainfluenza Virus (PI | 10-21-2010 |
20100285057 | HEAT TREATED BACTERINS, AND EMULSION VACCINES PREPARED FROM SUCH HEAT TREATED BACTERINS - Heat treated bacterins, a method of producing heat treated bacterins, and porcine emulsion vaccines prepared from such heat treated bacterins are disclosed. | 11-11-2010 |
20100330117 | PROCESS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS, NON-VIRAL BASED CANCERS, ALZHEIMERS'S DISEASE, MUSCULAR DYSTROPHY, ATTENTION DEFICIT DISORDER, ATTENTION DEFICIT HYPERACTIVITY DISORDER, COMPLEX REGIONAL PAIN SYNDROME, DIABETES, NEUROPATHIC PAIN, SPIDER ARTHRITIS, WEST NILE VIRUS, FIBROMYALGIA, SHINGLES, GOUT, MIGRAINE HEADACHES, SENILE DEMENTIA, POST POLIO SYNDROME, CENTRAL VIRUS DEAFNESS, ASTHMA, CHRONIC PAIN OF UNKNOWN ORIGIN AND HEPATITIS C - The present invention provides a composition and method for treating diseases associated with demyelination of the nerves, such as ALS, RA, Tremors/Parkinson's Disease, and MS, Alzheimer's disease, ALS, Guillain-Barre syndrome, atherosclerosis, schizophrenia, Tremors/Parkinsons's disease, senile dementia, Muscular Dystrophy, Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder, Complex Regional Pain Syndrome, Diabetes, Neuropathic Pain, Spider Arthritis West Nile Virus, Fibromyalgia, Shingles, Gout, Migraine Headaches, Post Polio Syndrome, Central Virus Deafness, Asthma, Chronic Pain Of Unknown Origin and Hepatitis C and for treating non-viral based cancers. By administering measured doses of an immunity-provoking agent and a bacterial antigen activator, patients suffering from ALS, RA, MS, Tremors/Parkinson's Disease, and prostate cancer and others realized immediate beneficial results with no side effects. | 12-30-2010 |
20110020392 | PROCESS FOR TREATMENT OF RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS AND NON-VIRAL BASED CANCERS - The present invention provides a composition and method for treating diseases associated with demyelination of the nerves, such as RA, Tremors/Parkinson's Disease, and MS, and for treating non-viral based cancers. By administering measured doses of an immunity-provoking agent and a bacterial antigen activator, patients suffering from RA, MS, Tremors/Parkinson's Disease, and prostrate cancer realized immediate beneficial results with no side effects. | 01-27-2011 |
20110020393 | Method of Producing Japanese Encephalitis Vaccine Stably Storable Over Long Time and Use of the Vaccine - The present inventors improved methods for inactivating Japanese encephalitis virus vaccines, and assessed the safety of vaccines produced by combining multiple vaccines. The present inventors successfully produced safer Japanese encephalitis vaccines by cell culture, which can be stored more stably over a long period than conventional Japanese encephalitis vaccines. Furthermore, it is also expected that the production methods can be used to produce other viral vaccines with excellent storage stability. | 01-27-2011 |
20110033495 | METHODS AND COMPOSITIONS FOR REDUCING THE IMPACT OF ENTERIC DISEASES - The present invention relates to the use of an immunogenic composition that comprises a PCV2 antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with an enteric infection, even more preferably, with enteric disease. The use relates to a method comprising the steps of administering the composition to an animal in need thereof, preferably prior to disease exposure. Administration of PCV2 antigen, preferably ORF2 of PCV2, lessens the incidence and reduces the severity of the enteric disease. | 02-10-2011 |
20110033496 | VACCINE FOR PROTECTION AGAINST LAWSONIA INTRACELLULARS - The present invention pertains to the use of a non-live carbohydrate containing composition, the carbohydrate being also found in live | 02-10-2011 |
20110033497 | VACCINE FOR PROTECTION AGAINST LAWSONIA INTRACELLULARIS, MYCOPLASMA HYOPNEUMONIAE AND PORCINE CIRCO VIRUS - The present invention pertains to a vaccine comprising in combination non-live antigens of | 02-10-2011 |
20110045017 | HIV VACCINE FOR MUCOSAL DELIVERY - This invention is directed to pharmaceutical compositions comprising an HIV antigen and a mucosal adjuvant and methods for raising an immune response in a subject by administering these compositions. Preferably, the pharmaceutical compositions of the invention can be used to treat or prevent HIV infection. | 02-24-2011 |
20110059126 | METHODS OF REDUCING VIRUCIDAL ACTIVITY IN PCV-2 COMPOSITIONS AND PCV-2 COMPOSITIONS WITH AN IMPROVED IMMUNOGENICITY - The present invention provides methods of reducing the vircidal activity of a composition comprising a PCV-2 antigen as well as antigenic preparations and immunogenic compositions comprising a PCV-2 antigen, wherein the virucidal activity has been reduced. In addition, the present invention also relates to a method of increasing the immunogenicity of an immunogenic composition comprising a PCV-2 antigen as well as immunogenic composition with an increased immunogenicity. | 03-10-2011 |
20110081376 | METHOD FOR USING INACTIVATED JAPANESE ENCEPHALITIS VIRUS PARTICLES AS ADJUVANT - A method for using inactivated Japanese encephalitis virus particles as an adjuvant of a vaccine is provided. A method for using inactivated Japanese encephalitis virus (JEV) particles as an adjuvant of various vaccines or a mixed vaccine, said JEV particles being obtained by inoculating JEV Beijing-1 strain to Vero cells, culturing said JEV-infected cells to give cultured cells or culture supernatant, purifying JEV particles from said cultured cells or culture supernatant and inactivating said JEV particles with formalin, a method for preparing a (mixed) vaccine which comprises a step of letting inactivated Japanese encephalitis virus be contained, and a mixed vaccine prepared by said method. | 04-07-2011 |
20110159033 | WEST NILE VIRUS VACCINE - The invention provides for immunogenic compositions against West Nile Virus. The immunogenic compositions, in alternate embodiments, also include other equine pathogens. The West Nile Virus composition of the present invention advantageously provides for protection against North American Dominant West Nile Virus strains or isolates. | 06-30-2011 |
20110177116 | Methods of Immunizing Pregnant Heifers at Three Months of Gestation - The present invention discloses methods for protecting newborn calves against neonatal diarrhea by vaccinating pregnant cows and/or pregnant heifers, while minimizing the number of separate occasions producers are required to assemble the cattle. | 07-21-2011 |
20110177117 | CHIMERIC RESPIRATORY SYNCYTIAL VIRUS POLYPEPTIDE ANTIGENS - Chimeric respiratory syncytial virus (RSV) polypeptide antigens are provided. The disclosed polypeptides include a first amino acid sequence comprising an F2 domain uncleavably joined to an F1 domain of a Respiratory Syncytial Virus (RSV) Fusion (F) protein polypeptide; and a second amino acid sequence comprising a portion of an RSV Attachment (G) protein polypeptide comprising an immunologically dominant epitope. The disclosure also provides nucleic acids that encode, and pharmaceutical compositions that contain, the chimeric RSV polypeptides, as well as methods for their production and use. | 07-21-2011 |
20110206727 | Multivalent Vaccines Based on Papaya Mosaic Virus and Uses Thereof - A multivalent vaccine composition that comprises a papaya mosaic virus (PapMV) component and one or more antigens is provided. The composition can further optionally comprise a | 08-25-2011 |
20110223194 | VACCINE - A method for stimulating the immune response to a vaccine applied to a mammalian subject includes the step of administering to the subject an effective amount of EtxB or a molecule having substantially equivalent activity, free from whole toxin and not linked to an antigen. | 09-15-2011 |
20110305725 | METHODS AND COMPOSITIONS FOR IMMUNIZING PIGS AGAINST PORCINE CIRCOVIRUS - The present invention relates to the isolation and identification of two new strains of type 2B porcine circovirus. These two new strains of porcine circovirus may be used for the preparation of vaccine or immunogenic compositions for immunizing pigs against postweaning multisystemic wasting syndrome (PMWS). Accordingly, the invention provides methods for eliciting a protective immune response against a pathogenic porcine circovirus by administering to a pig an immunogenically effective amount of a type 2B porcine circovirus vaccine or immunogenic composition comprising at least one of the porcine circoviruses having a nucleic acid sequence as set forth in SEQ ID NOs: 1 or 2, or at least one protein from at least one of the two new type 2B strains of porcine circovirus as described herein. The invention further relates to protection of a pig from any one or more of the symptoms or sequelae associated with PMWS. | 12-15-2011 |
20110318383 | HEMORRHAGIC FELINE CALICIVIRUS, CALICIVIRUS VACCINE AND METHOD FOR PREVENTING CALICIVIRUS INFECTION OR DISEASE - The present invention relates to a novel, isolated and purified hemorrhagic feline calicivirus FCV-DD1. The invention further embraces monovalent and multivalent vaccines containing the new FCV-DD1 strain. In addition, the invention encompasses methods of protecting felines against infection or preventing disease caused by feline calicivirus alone or in addition to other pathogens that comprises administering to the felines an immunologically effective amount of the monovalent and multivalent vaccines described herein. Also, the invention concerns methods for diagnosing or detecting the hemorrhagic feline calicivirus in a susceptible host, asymptomatic carrier and the like by detecting the presence of feline calicivirus FCV-DD1 or antibodies raised or produced against feline calicivirus FCV-DDI antigen. | 12-29-2011 |
20120034262 | Bovine Herpes Virus-1 Compositions, Vaccines and Methods - The disclosure relates generally to the treatment or prevention of disease in cattle. More particularly, the invention is directed to the production and use of modified bovine herpesvirus 1 (BHV-1) and their use in compositions and vaccines that protect cattle from BHV-1 infection while not suppressing the immunological response in the host. In one example, the invention is directed to the use of modified BHV-1, administered with additional immunogens, either through co-administration and/or through administration in combination vaccines, and the use of these vaccines for the protection of cattle from disease. In one example, use of the modified BHV-1 in the administered compositions facilitates an immune response to or against the additional immunogens. | 02-09-2012 |
20120058143 | STAPHYLOCOCCUS AUREUS PROTEINS AND NUCLEIC ACIDS - The invention provides proteins from | 03-08-2012 |
20120093854 | USE OF MYCOPLASMA BOVIS ANTIGEN - The present invention relates to combination vaccines and/or the combined use of immunogenic compositions for the treatment and/or prophylaxis of cattle against microbiological infections, wherein the infections are caused by | 04-19-2012 |
20120107348 | MULTIVALENT PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS - An improved method for recovering the protein expressed by open reading frame 2 from porcine circovirus type 2 is provided. Also provided is recombinant PCV2 ORF2 protein, and immunogenic compositions comprising PCV2 ORF2 protein. Moreover, multivalent combination vaccines are provided which include an immunological agent effective for reducing the incidence of or lessening the severity of PCV2 infection, preferably PCV2 ORF2 protein, or an immunogenic composition comprising PCV2 ORF2 protein, and at least one immunogenic active component of another disease-causing organism in swine, | 05-03-2012 |
20120135034 | Non-Integrating Retroviral Vector Vaccines - This invention relates to non-integrating, non-replicating retroviral vectors that cause an immune response in an animal host when administered to the host. The vectors transduce cells in the host, where they produce virus-like particles (VLPs), which stimulate an additional immune response in the host when they are released from the cells. The vectors are non-integrating, non-replicating retroviral vectors comprising long terminal repeats, a packaging sequence, and a heterologous promoter operably linked to one or more polynucleotide sequences that together encode the structural proteins of a virus. Methods of making and using the vectors are also disclosed. | 05-31-2012 |
20120148620 | COMPOSITIONS AND METHODS FOR VACCINATING CATTLE - The present invention relates to compositions, uses thereof, and methods of vaccinating cattle, particularly cows and heifers, against | 06-14-2012 |
20120164170 | Porcine Circovirus Type 2 (PCV2), Immunogenic Composition Containing the Same, Test Kit, and Application Thereof - The invention relates to a novel porcine circovirus type 2 (PCV2) strain. The invention also relates to immunogenic compositions containing the novel PCV2 strain, PCV2 test kits, and applications of the novel PCV2 strain. | 06-28-2012 |
20120231033 | INACTIVATED POULTRY VACCINE - The present invention relates to pharmaceutical compositions comprising an immunizing amount of inactivated Newcastle disease and an adjuvant for use in the protection of poultry against Newcastle disease, to the use of an immunogenic amount of an inactivated Newcastle disease virus and an adjuvant for the manufacture of a booster vaccine for the vaccination of a chicken or turkey, and to a kit-of-parts comprises a container comprising an inactivated Newcastle disease virus and an adjuvant for a priming vaccination of a chicken or turkey and a container comprising an inactivated Newcastle disease virus and an adjuvant for a boosting vaccination of a chicken or turkey. | 09-13-2012 |
20120269847 | ANTIGEN PURIFICATION PROCESS FOR PERTACTIN ANTIGEN - p69 antigen is purified by immobilised metal affinity chromatography. | 10-25-2012 |
20130039941 | VACCINE COMPRISING INACTIVATED CELLS OF HAEMOPHILUS PARASUIS BACTERIA OF SEROTYPE 5 - The present invention pertains to the use of | 02-14-2013 |
20130045228 | VACCINE FOR PROTECTION AGAINST LAWSONIA INTRACELLULARIS - The present invention pertains to the use of a non-live carbohydrate containing composition, the carbohydrate being also found in live | 02-21-2013 |
20130122040 | FERMENTATION MEDIA FREE OF ANIMAL-DERIVED COMPONENTS FOR PRODUCTION OF DIPHTHERIA TOXOIDS SUITABLE FOR HUMAN VACCINE USE - The present invention relates to a fermentation medium for cultivating | 05-16-2013 |
20130122041 | ATTENUATED EHRLICHIOSIS VACCINE - The present invention relates to an attenuated strain of | 05-16-2013 |
20130183337 | KIT FOR THE PREPARATION OF A VACCINATING AGENT - A kit, a method of using it and a process for preparing a vaccine for immunization against the disease Porcine Circovirus Disease and/or Enzootic Pneumonia in pigs are proposed, in which a first container is only partly filled with a first vaccine and a second container is filled with a second vaccine, the second vaccine being transferred into the first container through an adapter device, when a closure device is penetrated for the first and/or only time, and the vaccinating agent is prepared therein, thus making the operation simple, less error-prone and more hygienic, while reducing the materials required. The adapter device has a pair of oppositely facing piercing elements formed of one of needles, hollow, spikes, wedges with at least one through passage extending through both piercing elements, each of the containers being pierced by a respective one of the piercing elements creating a fluid connection between the containers. | 07-18-2013 |
20130183338 | VACCINE FOR PROTECTION AGAINST LAWSONIA INTRACELLULARIS, MYCOPLASMA HYOPNEUMONIAE AND PORCINE CIRCO VIRUS - The present invention pertains to a vaccine comprising in combination non-live antigens of | 07-18-2013 |
20130195913 | LIVE ATTENUATED PARVOVIRUS - The invention relates to live attenuated parvoviruses, their uses, vaccines comprising such live attenuated parvoviruses, as well as methods for their production. | 08-01-2013 |
20130236492 | ADJUVANTED FORMULATIONS OF BOOSTER VACCINES - The invention improves TdaP vaccines by including a TLR agonist in them. This agonist can provide stronger protection, longer-lasting protection, and/or can reduce the amount of antigen which is required to achieve a particular immune response. | 09-12-2013 |
20130273100 | VACCINES WITH LIVE BACTERIAL ISOLATES FOR SYSTEMIC ADMINISTRATION - The present invention pertains to vaccines suitable for administering systemically that comprise live aro mutant bacteria, an adjuvant, an aromatic supplement, or both an adjuvant and an aromatic supplement. The present invention also pertains to the manufacture of such a vaccine and a method of protecting an animal by administration of the vaccine. | 10-17-2013 |
20130302369 | Immunogenic Bordetella Bronchiseptica Compositions - Provided herein are compositions, combinations, and methods comprising | 11-14-2013 |
20130315951 | COMPOSITIONS AND METHODS FOR STIMULATING AN IMMUNE RESPONSE AGAINST INFECTIOUS AGENTS - The invention provides for oral compositions for safely stimulating an immune response to mucoadhesive antigens for protection against infectious agents, particularly influenza viruses using heat-labile, mutant | 11-28-2013 |
20130337007 | SALMONID ALPHAVIRUS PROTEIN E2 - The present invention relates to Salmonid alphavirus E2-protein expressed in a bacterial expression system, its use in medicine, vaccines comprising such protein, methods for the preparation of such proteins and methods for the preparation of vaccines comprising such proteins. | 12-19-2013 |
20140004144 | Attenuated Streptococcus suis Vaccines and Methods of Making and Use Thereof | 01-02-2014 |
20140023678 | Method of Providing Protective Immunity against Heterologous Leptospira Strains - The present invention provides compositions and methods for eliciting protective immunity in animals against | 01-23-2014 |
20140037680 | NOVEL METHOD - This disclosure provides methods for protecting infants against disease caused by respiratory syncytial virus (RSV) through maternal immunization using recombinant respiratory syncytial virus (RSV) antigens to reduce the incidence or severity of RSV infection in young infants. | 02-06-2014 |
20140079732 | COMBINATION VACCINES - The present invention relates to the field of vaccines. More specifically the present invention relates to compositions and methods for enhancing immune responses induced by vaccines, including vaccines targeted at secondary infections and conditions associated with influenza infection. | 03-20-2014 |
20140079733 | Compositions for Canine Respiratory Disease Complex - Provided herein are compositions comprising a canine influenza virus and a canine respiratory coronavirus. They can further comprise | 03-20-2014 |
20140105930 | BOVINE VACCINES AND METHODS - Methods for stimulating immune responses in a bovine animal susceptible to infection by | 04-17-2014 |
20140120135 | AQUEOUS COMPOSITION COMPRISING A BIOLOGICAL ANTIGEN AND AN ACRYLIC ACID POLYMER - The current invention pertains to an aqueous composition containing a biological antigen and an acrylic acid polymer, wherein the composition comprises an electrolyte to provide an osmolarity higher than the osmolarity of a 0.9% (w/v) sodium chloride solution in water. The invention also pertains to the acrylic acid polymer for use in a one shot vaccine against porcine circo virus 2 (PCV2) and optionally | 05-01-2014 |
20140127259 | COMPOSITIONS AND METHODS FOR VACCINATING CATTLE - The present invention relates to compositions, uses thereof, and methods of vaccinating cattle, particularly cows and heifers, against | 05-08-2014 |
20140205631 | Stimulation of vaccination by angiotensin peptides - The present invention provides angiotensin peptide compositions and methods for use of the compositions in vaccination. | 07-24-2014 |
20140322267 | ORF2 PROTEIN OF PCV2 SUBTYPE A (PCV2A) FOR USE IN CROSS-PROTECTION - Vaccination methods to control PCV2 infection with different PCV2 subtypes are disclosed. Specifically, a PCV2 subtype a (PCV2a) ORF2 proteins or immunogenic compositions comprising a PCV2a ORF2 protein are used in a method for the treatment or prevention of an infection with PCV2 of a different subtype, the reduction, prevention or treatment of clinical signs caused by an infection with PCV2 of a different subtype, or the prevention or treatment of a disease caused by an infection with PCV2 of a different subtype. | 10-30-2014 |
20140341947 | IMMUNOGENIC COMPOSITIONS COMPRISING LAWSONIA INTRACELLULARIS - The present invention provides combination vaccines that comprise an immunological agent effective for reducing the incidence of or lessening the severity of PPE caused by | 11-20-2014 |
20140363466 | METHOD OF TREATING PREGNANT COWS AND/OR HEIFERS - The present invention relates to combination vaccines for the prophylaxis and treatment of microbiological infections in cattle which comprise an attenuated bovine viral diarrhea virus (BVDV) for the the prophylaxis and treatment of BVDV caused infections. The invention also relates to a method of vaccinating a pregnant cow. | 12-11-2014 |
20150037370 | DIATOM-BASED VACCINES - This invention provides diatom-based vaccines. | 02-05-2015 |
20150086586 | ACELLULAR PERTUSSIS VACCINE - Described are acellular pertussis (aP) vaccine compositions comprising | 03-26-2015 |
20150125486 | ADJUVANTED FORMULATIONS OF PEDIATRIC ANTIGENS - An immunogenic composition comprising a diphtheria toxoid, a tetanus toxoid, a pertussis toxoid, an aluminium salt adjuvant, and a TLR4 agonist. Preferably, the TLR4 agonist and/or at least one of the toxoids is/are adsorbed to the aluminium salt adjuvant. | 05-07-2015 |
20150125487 | Attenuated Pasteurella Multocida Vaccines & Methods of Making & Use Thereof - The present invention provides attenuated | 05-07-2015 |
20150140033 | C. PERFRINGENS ALPHA TOXOID VACCINE - The present invention describes vaccines that comprise | 05-21-2015 |
20150147354 | Method of Producing a Designer Blood Product, Method of Using a Designer Blood Product, and Diet for Selectively Enhancing Blood Profile - A method of making a blood product for administration to patient animals to prevent or mitigate a specific condition or disease includes pre-treating one or more donor animals, collecting blood from the donor animals after pre-treatment, and processing the collected blood to make a blood product for administering to one or more patient animals. The pre-treatment step is designed to optimize the levels of one or more components in the blood that play a role in preventing or treating a specific condition or disease. | 05-28-2015 |
20150359878 | USE OF REPLICATION DEFICIENT HSV-1 AS A VACCINE VECTOR FOR THE DELI VARY OF HIV-1 TAT ANTIGEN - A vaccine for a DNA virus, especially HSV1, comprises an expression vector for HIV1 Tat, wherein the vector is an avirulent form of said DNA virus, and elicits cellular responses to cryptic epitopes of the DNA virus, as well as eliciting a detectable IgG response. | 12-17-2015 |
20160008449 | CROSS-PROTECTION OF BOVINES AGAINST B. trehalosi INFECTION BY A MULTI-VALENT VACCINE | 01-14-2016 |
20160030556 | Bovine Virus Vaccines That Are Liquid Stable - The present invention discloses liquid stable bovine vaccines that comprise a live attenuated virus, and a sugar alcohol. The present invention also discloses the manufacture of such vaccines and methods of protecting an animal by administration of such vaccines. | 02-04-2016 |
20160082095 | VACCINE FOR PCV2 AND MYCOPLASMA - A premixed multivalent vaccine in ready-to-use form comprising PCV2 ORF2 capsid antigen and | 03-24-2016 |
20160158338 | METHODS OF STIMULATING IMMUNITY EMPLOYING DENGUE VIRAL ANTIGENS - Compositions that include at least a portion of at least one pathogen-associated molecular pattern and at least a portion of at least one member selected from the group consisting of a Den1 viral envelope protein, a Den2 viral envelope protein, a Den3 viral envelope protein and a Den4 viral envelope protein are employed in methods to stimulate a protective immune response in a subject. | 06-09-2016 |